These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. den Boer FC, Wippermann BW, Blokhuis TJ, Patka P, Bakker FC, Haarman HJ. J Orthop Res; 2003 May; 21(3):521-8. PubMed ID: 12706026 [Abstract] [Full Text] [Related]
7. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, Tezval M, Daub F, Martens T, Witzenhausen P, Dullin C, Stuermer KM. Bone; 2010 Sep; 47(3):480-92. PubMed ID: 20580683 [Abstract] [Full Text] [Related]
8. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, Seki A, Sun YX, Yamamoto T. Bone; 2007 Jun; 40(6):1475-82. PubMed ID: 17369013 [Abstract] [Full Text] [Related]
9. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Einhorn TA. J Bone Joint Surg Am; 2005 Apr; 87(4):731-41. PubMed ID: 15805200 [Abstract] [Full Text] [Related]
10. Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing. Warden SJ, Komatsu DE, Rydberg J, Bond JL, Hassett SM. Bone; 2009 Mar; 44(3):485-94. PubMed ID: 19071238 [Abstract] [Full Text] [Related]
11. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. Chen X, Schmidt AH, Tsukayama DT, Bourgeault CA, Lew WD. J Bone Joint Surg Am; 2006 Jul; 88(7):1510-23. PubMed ID: 16818977 [Abstract] [Full Text] [Related]
14. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. Little DG, McDonald M, Bransford R, Godfrey CB, Amanat N. J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978 [Abstract] [Full Text] [Related]
15. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. Luppen CA, Blake CA, Ammirati KM, Stevens ML, Seeherman HJ, Wozney JM, Bouxsein ML. J Bone Miner Res; 2002 Feb; 17(2):301-10. PubMed ID: 11811561 [Abstract] [Full Text] [Related]
16. Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model. Lin EA, Liu CJ, Monroy A, Khurana S, Egol KA. J Orthop Trauma; 2012 Dec; 26(12):719-23. PubMed ID: 22932751 [Abstract] [Full Text] [Related]
17. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. J Orthop Res; 2004 Jan; 22(1):58-65. PubMed ID: 14656660 [Abstract] [Full Text] [Related]
18. Comparative study of the effect of PTH (1-84) and strontium ranelate in an experimental model of atrophic nonunion. Pérez Núñez MI, Ferreño Blanco D, Alfonso Fernández A, Casado de Prado JA, Sánchez Crespo M, De la Red Gallego M, Pascual Carra A, Rodriguez López T, Diego Cavia S, Garcés Zarzalejo C, Mayorga Fernández M, Ruiz Martínez E, Carrascal Vaquero I, Riancho Moral JA. Injury; 2015 Dec; 46(12):2359-67. PubMed ID: 26521993 [Abstract] [Full Text] [Related]